Multifunctional Tandem Peptide Modified Paclitaxel-Loaded Liposomes for the Treatment of Vasculogenic Mimicry and Cancer Stem Cells in Malignant Glioma

ACS Applied Materials and Interfaces

Volumn 7, Issue 30, 2015, Pages 16792-16801

  Liu, Yayuan ^a   Mei, Ling ^a   Yu, Qianwen ^a   Xu, Chaoqun ^b   Qiu, Yue ^a   Yang, Yuting ^a   Shi, Kairong ^a   Zhang, Qianyu ^a   Gao, Huile ^a   Zhang, Zhirong ^a   He, Qin ^a  

^a SICHUAN UNIVERSITY   (China)

^b Sichuan Academy of Chinese Medicine Sciences   (China)

Author keywords

antiglioma; brain cancer stem cells; cell penetrating peptide; tandem peptide; vasculogenic mimicry

Indexed keywords

BLOOD; CELLS; CHEMOTHERAPY; CYTOLOGY; DIAGNOSIS; DISEASES; DRUG DOSAGE; DRUG THERAPY; LIPOSOMES; PEPTIDES; PHARMACODYNAMICS; TUMORS;

ANTIGLIOMA; BRAIN CANCER; CANCER STEM CELLS; CELL-PENETRATING PEPTIDE; DRUG DELIVERY SYSTEM; INHIBITION EFFECT; SAFETY EVALUATIONS; VASCULOGENIC;

STEM CELLS;

ANGIOGENESIS INHIBITOR; ANTINEOPLASTIC AGENT; ARGINYL-GLYCYL-ASPARTIC ACID; LIPOSOME; OLIGOPEPTIDE; PACLITAXEL;

ANIMAL; APOPTOSIS; BAGG ALBINO MOUSE; BRAIN NEOPLASMS; CANCER STEM CELL; CELL SURVIVAL; CHEMISTRY; DRUG EFFECTS; GLIOMA; METABOLISM; NEOVASCULARIZATION, PATHOLOGIC; PATHOLOGY; TREATMENT OUTCOME; TUMOR CELL LINE;

ANGIOGENESIS INHIBITORS; ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; BRAIN NEOPLASMS; CELL LINE, TUMOR; CELL SURVIVAL; GLIOMA; LIPOSOMES; MICE, INBRED BALB C; NEOPLASTIC STEM CELLS; NEOVASCULARIZATION, PATHOLOGIC; OLIGOPEPTIDES; PACLITAXEL; TREATMENT OUTCOME;

EID: 84938613706     PISSN: 19448244     EISSN: 19448252     Source Type: Journal    
DOI: 10.1021/acsami.5b04596     Document Type: Article

References (52)

1. Wick, W.; Hartmann, C.; Engel, C.; Stoffels, M.; Felsberg, J.; Stockhammer, F.; Sabel, M. C.; Koeppen, S.; Ketter, R.; Meyermann, R. et al. NOA-04 Randomized Phase III Trial of Sequential Radiochemotherapy of Anaplastic Glioma with Procarbazine, Lomustine, and Vincristine or Temozolomide J. Clin. Oncol. 2009, 27 (35) 5874-5880 10.1200/JCO.2009.23.6497
2. Anderson, M. D.; Hamza, M. A.; Hess, K. R.; Puduvalli, V. K. Implications of Bevacizumab Discontinuation in Adults with Recurrent Glioblastoma Neuro. Oncol. 2014, 16 (6) 823-828 10.1093/neuonc/nou021
3. Bhujbal, S. V.; de Vos, P.; Niclou, S. P. Drug and Cell Encapsulation: Alternative Delivery Options for the Treatment of Malignant Brain Tumors Adv. Drug Delivery Rev. 2014, 67, 142-153 10.1016/j.addr.2014.01.010
4. Cheng, Y.; Morshed, R. A.; Auffinger, B.; Tobias, A. L.; Lesniak, M. S. Multifunctional Nanoparticles for Brain Tumor Imaging and Therapy Adv. Drug Delivery Rev. 2014, 66, 42-57 10.1016/j.addr.2013.09.006
5. Kreuter, J. Drug Delivery to the Central Nervous System by Polymeric Nanoparticles: What do we Know? Adv. Drug Delivery Rev. 2014, 71, 2-14 10.1016/j.addr.2013.08.008
6. Yan, H.; Wang, L.; Wang, J.; Weng, X.; Lei, H.; Wang, X.; Jiang, L.; Zhu, J.; Lu, W.; Wei, X.; Cong, L. Two-Order Targeted Brain Tumor Imaging by Using an Optical/Paramagnetic Nanoprobe Across the Blood Brain Barrier ACS Nano 2011, 6 (1) 410-420 10.1021/nn203749v
7. Chen, Y.; Liu, L. Modern Methods for Delivery of Drugs Across the Blood-Brain Barrier Adv. Drug Delivery Rev. 2012, 64 (7) 640-665 10.1016/j.addr.2011.11.010
8. Ling, G.; Wang, S.; Song, Z.; Sun, X.; Liu, Y.; Jiang, X.; Cai, Y.; Du, M.; Ke, Y. Transforming Growth Factor-b is Required for Vasculogenic Mimicry Formation in Glioma Cell Line U251MG Cancer Biol. Ther. 2011, 12 (11) 978-988 10.4161/cbt.12.11.18155
9. Huang, M.; Ke, Y.; Sun, X.; Yu, L.; Yang, Z.; Zhang, Y.; Du, M.; Wang, J.; Liu, X.; Huang, S. Mammalian Target of Rapamycin Signaling is Involved in the Vasculogenic Mimicry of Glioma via Hypoxia-Inducible Factor-1α Oncol. Rep. 2014, 32 (5) 1973-1980 10.3892/or.2014.3454
10. Chen, Y.; Jing, Z.; Luo, C.; Zhuang, M.; Xia, J.; Chen, Z.; Wang, Y. Vasculogenic Mimicry-Potential Target for Glioblastoma Therapy: an in Vitro and in Vivo Study Med. Oncol. 2012, 29 (1) 324-331 10.1007/s12032-010-9765-z
11. Kirschmann, D. A.; Seftor, E. A.; Hardy, K. M.; Seftor, R. E.; Hendrix, M. J. Molecular Pathways: Vasculogenic Mimicry in Tumor Cells: Diagnostic and Therapeutic Implications Clin. Cancer Res. 2012, 18 (10) 2726-2732 10.1158/1078-0432.CCR-11-3237
12. Chen, Y.-S.; Chen, Z.-P. Vasculogenic Mimicry: a Novel Target for Glioma Therapy Aizheng 2014, 33 (2) 74 10.5732/cjc.012.10292
13. Liu, X.-m.; Zhang, Q.-p.; Mu, Y.-g.; Zhang, X.-h.; Sai, K.; Pang, J. C.-S.; Ng, H.-K.; Chen, Z.-p. Clinical Significance of Vasculogenic Mimicry in Human Gliomas J. Neuro-Oncol. 2011, 105 (2) 173-179 10.1007/s11060-011-0578-5
14. Sarvi, S.; Mackinnon, A. C.; Avlonitis, N.; Bradley, M.; Rintoul, R. C.; Rassl, D. M.; Wang, W.; Forbes, S. J.; Gregory, C. D.; Sethi, T. CD133+ Cancer Stem-Like Cells in Small Cell Lung Cancer are Highly Tumorigenic and Chemoresistant but Sensitive to a Novel Neuropeptide Antagonist Cancer Res. 2014, 74 (5) 1554-1565 10.1158/0008-5472.CAN-13-1541
15. Singh, S. K.; Clarke, I. D.; Terasaki, M.; Bonn, V. E.; Hawkins, C.; Squire, J.; Dirks, P. B. Identification of a Cancer Stem Cell in Human Brain Tumors Cancer Res. 2003, 63 (18) 5821-5828
16. Singh, S. K.; Hawkins, C.; Clarke, I. D.; Squire, J. A.; Bayani, J.; Hide, T.; Henkelman, R. M.; Cusimano, M. D.; Dirks, P. B. Identification of Human Brain Tumour Initiating Cells Nature 2004, 432 (7015) 396-401 10.1038/nature03128
17. Zhu, Z.; Khan, M. A.; Weiler, M.; Blaes, J.; Jestaedt, L.; Geibert, M.; Zou, P.; Gronych, J.; Bernhardt, O.; Korshunov, A. et al. Targeting Self-Renewal in High-Grade Brain Bumors Leads to Loss of Brain Tumor Stem Cells and Prolonged Survival Cell stem cell 2014, 15 (2) 185-198 10.1016/j.stem.2014.04.007
18. Chen, H.; Tang, L.; Qin, Y.; Yin, Y.; Tang, J.; Tang, W.; Sun, X.; Zhang, Z.; Liu, J.; He, Q. Lactoferrin-Modified Procationic Liposomes as a Novel Drug Carrier for Brain Delivery Eur. J. Pharm. Sci. 2010, 40 (2) 94-102 10.1016/j.ejps.2010.03.007
19. Li, J.; Zhou, L.; Ye, D.; Huang, S.; Shao, K.; Huang, R.; Han, L.; Liu, Y.; Liu, S.; Ye, L. et al. Choline - Derivate-Modified Nanoparticles for Brain-Targeting Gene Delivery Adv. Mater. 2011, 23 (39) 4516-4520 10.1002/adma.201101899
20. Qin, Y.; Chen, H.; Yuan, W.; Kuai, R.; Zhang, Q.; Xie, F.; Zhang, L.; Zhang, Z.; Liu, J.; He, Q. Liposome Formulated with TAT-Modified Cholesterol for Enhancing the Brain Delivery Int. J. Pharm. 2011, 419 (1) 85-95 10.1016/j.ijpharm.2011.07.021
21. Hervé, F.; Ghinea, N.; Scherrmann, J.-M. CNS Delivery via Adsorptive Transcytosis AAPS J. 2008, 10 (3) 455-472 10.1208/s12248-008-9055-2
22. Qin, Y.; Chen, H.; Zhang, Q.; Wang, X.; Yuan, W.; Kuai, R.; Tang, J.; Zhang, L.; Zhang, Z.; Zhang, Q. et al. Liposome Formulated with TAT-Modified Cholesterol for Improving Brain Delivery and Therapeutic Efficacy on Brain Glioma in Animals Int. J. Pharm. 2011, 420 (2) 304-312 10.1016/j.ijpharm.2011.09.008
23. Gong, C.; Li, X.; Xu, L.; Zhang, Y.-H. Target Delivery of a Gene into the Brain Using the RVG29-Oligoarginine Peptide Biomaterials 2012, 33 (12) 3456-3463 10.1016/j.biomaterials.2011.12.017
24. Rousselle, C.; Clair, P.; Lefauconnier, J.-M.; Kaczorek, M.; Scherrmann, J.-M.; Temsamani, J. New Advances in the Transport of Doxorubicin Through the Blood-Brain Barrier by a Peptide Vector-Mediated Strategy Mol. Pharmacol. 2000, 57 (4) 679-686
25. Deshayes, S.; Morris, M.; Divita, G.; Heitz, F. Cell-Penetrating Peptides: Tools for Intracellular Delivery of Therapeutics Cell. Mol. Life Sci. 2005, 62 (16) 1839-1849 10.1007/s00018-005-5109-0
26. Liu, Y.; Ran, R.; Chen, J.; Kuang, Q.; Tang, J.; Mei, L.; Zhang, Q.; Gao, H.; Zhang, Z.; He, Q. Paclitaxel Loaded Liposomes Decorated with a Multifunctional Tandem Peptide for Glioma Targeting Biomaterials 2014, 35 (17) 4835-4847 10.1016/j.biomaterials.2014.02.031
27. Li, X.-Y.; Zhao, Y.; Sun, M.-G.; Shi, J.-F.; Ju, R.-J.; Zhang, C.-X.; Li, X.-T.; Zhao, W.-Y.; Mu, L.-M.; Zeng, F. et al. Multifunctional Liposomes Loaded with Paclitaxel and Artemether for Treatment of Invasive Brain Glioma Biomaterials 2014, 35 (21) 5591-5604 10.1016/j.biomaterials.2014.03.049
28. Kibria, G.; Hatakeyama, H.; Ohga, N.; Hida, K.; Harashima, H. Dual-Ligand Modification of PEGylated Liposomes Shows Better Cell Selectivity and Efficient Gene Delivery J. Controlled Release 2011, 153 (2) 141-148 10.1016/j.jconrel.2011.03.012
29. Vachutinsky, Y.; Oba, M.; Miyata, K.; Hiki, S.; Kano, M. R.; Nishiyama, N.; Koyama, H.; Miyazono, K.; Kataoka, K. Antiangiogenic Gene Therapy of Experimental Pancreatic Tumor by SFlt-1 Plasmid DNA Carried by RGD-Modified Crosslinked Polyplex Micelles J. Controlled Release 2011, 149 (1) 51-57 10.1016/j.jconrel.2010.02.002
30. Cabrera, M. C.; Hollingsworth, R. E.; Hurt, E. M.; Hurt, E.; Way, O. M. Cancer Stem Cell Plasticity and Tumor Hierarchy World J. Stem Cells 2015, 7 (1) 27-36 10.4252/wjsc.v7.i1.27
31. Leong, H. S.; Chong, F. T.; Sew, P. H.; Lau, D. P.; Wong, B. H.; Teh, B.-T.; Tan, D. S.; Iyer, N. G. Targeting Cancer Stem Cell Plasticity Through Modulation of Epidermal Growth Factor and Insulin-Like Growth Factor Receptor Signaling in Head and Neck Squamous Cell Cancer Stem Cells Transl. Med. 2014, 3 (9) 1055-1065 10.5966/sctm.2013-0214
32. Ju, R.-J.; Li, X.-T.; Shi, J.-F.; Li, X.-Y.; Sun, M.-G.; Zeng, F.; Zhou, J.; Liu, L.; Zhang, C.-X.; Zhao, W.-Y. et al. Liposomes, Modified with PTD HIV-1 Peptide, Containing Epirubicin and Celecoxib, to Target Vasculogenic Mimicry Channels in Invasive Breast Cancer Biomaterials 2014, 35 (26) 7610-7621 10.1016/j.biomaterials.2014.05.040
33. Karlsson, M. O.; Molnar, V.; Bergh, J.; Freijs, A.; Larsson, R. A General Model for Time-Dissociated Pharmacokinetic-Pharmacodynamic Relationships Exemplified by Paclitaxel Myelosuppression Clin. Pharmacol. Ther. 1998, 63 (1) 11-25 10.1016/S0009-9236(98)90117-5
34. Goldberg, D.; Winfield, D. Diagnostic Accuracy of Serum Enzyme Assays for Myocardial Infarction in a General Hospital Population Heart 1972, 34 (6) 597 10.1136/hrt.34.6.597
35. Ozer, J. S.; Chetty, R.; Kenna, G.; Palandra, J.; Zhang, Y.; Lanevschi, A.; Koppiker, N.; Souberbielle, B. E.; Ramaiah, S. K. Enhancing the Utility of Alanine Aminotransferase as a Reference Standard Biomarker for Drug-Induced Liver Injury Regul. Toxicol. Pharmacol. 2010, 56 (3) 237-246 10.1016/j.yrtph.2009.11.001
36. Xin, H.; Sha, X.; Jiang, X.; Zhang, W.; Chen, L.; Fang, X. Anti-Glioblastoma Efficacy and Safety of Paclitaxel-Loading Angiopep-Conjugated Dual Targeting PEG-PCL Nanoparticles Biomaterials 2012, 33 (32) 8167-8176 10.1016/j.biomaterials.2012.07.046
37. Li, S.-D.; Huang, L. Pharmacokinetics and Biodistribution of Nanoparticles Mol. Pharmaceutics 2008, 5 (4) 496-504 10.1021/mp800049w
38. Gao, H.; He, Q. The Interaction of Nanoparticles with Plasma Proteins and the Consequent Influence on Nanoparticles Behavior Expert Opin. Drug Delivery 2014, 11 (3) 409-20 10.1517/17425247.2014.877442
39. Huang, Y.; Jiang, Y.; Wang, H.; Wang, J.; Shin, M. C.; Byun, Y.; He, H.; Liang, Y.; Yang, V. C. Curb Challenges of the "Trojan Horse" Approach: Smart Strategies in Achieving Effective yet Safe Cell-Penetrating Peptide-Based Drug Delivery Adv. Drug Delivery Rev. 2013, 65 (10) 1299-1315 10.1016/j.addr.2012.11.007
40. Milletti, F. Cell-Penetrating Peptides: Classes, Origin, and Current Landscape Drug Discovery Today 2012, 17 (15) 850-860 10.1016/j.drudis.2012.03.002
41. Zhang, Q.; Tang, J.; Fu, L.; Ran, R.; Liu, Y.; Yuan, M.; He, Q. A pH-Responsive α-Helical Cell Penetrating Peptide-Mediated Liposomal Delivery System Biomaterials 2013, 34 (32) 7980-7993 10.1016/j.biomaterials.2013.07.014
42. Gu, B.; Xie, C.; Zhu, J.; He, W.; Lu, W. Folate-PEG-CKK2-DTPA, a Potential Carrier for Lymph-Metastasized Tumor Targeting Pharm. Res. 2010, 27 (5) 933-942 10.1007/s11095-010-0100-3
43. Svensen, N.; Walton, J. G.; Bradley, M. Peptides for Cell-Selective Drug Delivery Trends Pharmacol. Sci. 2012, 33 (4) 186-192 10.1016/j.tips.2012.02.002
44. Wen, Y.; Roudebush, S. L.; Buckholtz, G. A.; Goehring, T. R.; Giannoukakis, N.; Gawalt, E. S.; Meng, W. S. Coassembly of Amphiphilic Peptide EAK16-II with Histidinylated Analogues and Implications for Functionalization of β-Sheet Fibrils in Vivo Biomaterials 2014, 35 (19) 5196-5205 10.1016/j.biomaterials.2014.03.009
45. de Mendoza, F. H.; Rodriguez, E. A. Cancer Stem Cells in Brain Tumors. In Stem Cells in Cancer: Should We Believe or Not?; Springer: New York, 2014; pp 229-243.
46. Raha, D.; Wilson, T. R.; Peng, J.; Peterson, D.; Yue, P.; Evangelista, M.; Wilson, C.; Merchant, M.; Settleman, J. The Cancer Stem Cell Marker Aldehyde Dehydrogenase is Required to Maintain a Drug-Tolerant Tumor Cell Subpopulation Cancer Res. 2014, 74 (13) 3579-3590 10.1158/0008-5472.CAN-13-3456
47. Dean, M.; Fojo, T.; Bates, S. Tumour Stem Cells and Drug Resistance Nat. Rev. Cancer 2005, 5 (4) 275-284 10.1038/nrc1590
48. Donnenberg, V. S.; Donnenberg, A. D. Multiple Drug Resistance in Cancer Revisited: the Cancer Stem Cell Hypothesis J. Clin. Pharmacol. 2005, 45 (8) 872-877 10.1177/0091270005276905
49. Mallini, P.; Lennard, T.; Kirby, J.; Meeson, A. Epithelial-to-Mesenchymal Transition: What is the Impact on Breast Cancer Stem Cells and Drug Resistance Cancer Treat. Rev. 2014, 40 (3) 341-348 10.1016/j.ctrv.2013.09.008
50. Kannan, N.; Nguyen, L. V.; Eaves, C. J. Integrin [beta] 3 Links Therapy Resistance and Cancer Stem Cell Properties Nat. Cell Biol. 2014, 16 (5) 397-399 10.1038/ncb2960
51. Itzhaki, O.; Greenberg, E.; Shalmon, B.; Kubi, A.; Treves, A. J.; Shapira-Frommer, R.; Avivi, C.; Ortenberg, R.; Ben-Ami, E.; Schachter, J. et al. Nicotinamide Inhibits Vasculogenic Mimicry, an Alternative Vascularization Pathway Observed in Highly Aggressive Melanoma PLoS One 2013, 8 (2) e57160 10.1371/journal.pone.0057160
52. Wang, H.; Sun, W.; Zhang, W.-Z.; Ge, C.-Y.; Zhang, J.-T.; Liu, Z.-Y.; Fan, Y.-Z. Inhibition of Tumor Vasculogenic Mimicry and Prolongation of Host Survival in Highly Aggressive Gallbladder Cancers by Norcantharidin via Blocking the Ephrin Type a Receptor 2/Focal Adhesion Kinase/Paxillin Signaling Pathway PLoS One 2014, 9 (5) e96982 10.1371/journal.pone.0096982